Scangos George A

Scangos George A is listed in filings as Director at Voyager Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 23, 2026, including sale activity. Recent filings connect the profile to Voyager Therapeutics, Inc. (VYGR), Vir Biotechnology, Inc. (VIR), and Agilent Technologies Inc (A). The current snapshot covers public activity from Oct 24, 2024 to Mar 23, 2026. Reported amounts are shown as $78.7K to $95.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.